Ad
related to: fda s- Contact Us
Call + Email
24/7 Live Chat
- Verify: FDA Registration
Free Tool To Verify That Your US
FDA Registration Is Currently Valid
- FDA Registration
Quick & Easy
Register Your Business
- Food & Beverage
Full Service
Everything You Need
- Contact Us
Search results
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters· 5 hours ago, opens new tab experimental blood test for a cancer of colon or rectum may fail to detect some...
Candy, dog food, cream cheese: Here’s a list of items being recalled this month
Birmingham News· 1 hour agoThe Food and Drug Administration and the Food Safety and Inspection Service (FSIS) have issued at...
Larimar's Friedreich's ataxia program free at last from FDA hold
FierceBiotech· 6 hours agoLarimar Therapeutics’ Friedreich’s ataxia program is free at last, with the FDA fully lifting a...
FDA seeks AI tech to predict, detect Parkinson’s symptoms
MedTech Dive via Yahoo Finance· 8 hours agoBy testing artificial intelligence and machine learning models, the agency hopes to come up with...
Maddow Blog | Controversial judge blocks enforcement of background check rule
MSNBC via Yahoo News· 3 hours agoMatthew Kacsmaryk, a Trump-appointed jurist in Texas, has earned a reputation as one of the nation’s...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
AOL· 6 hours agoThe reviewers, however, said a benefit would be that the test may increase compliance with screening for colorectal cancer and detect it in earlier stages, potentially helping cure patients ...
Roche Breast Cancer Medicine to Get Expedited FDA Review
Bloomberg· 9 hours agoRoche Holding AG said an experimental breast-cancer treatment will get an expedited review from US...
US FDA staff says Guardant’s test may fail to detect some pre-cancerous tumors
WHTC 1450 Holland· 5 hours ago(Reuters) -The U.S. Food and Drug Administration's staff reviewers on Tuesday raised concerns that...
FDA Approves Boehringer Ingelheim’s CYLTEZO® Biosimilar to Humira for Multiple Chronic Inflammatory...
JD Supra· 13 hours agoCYLTEZO was first approved in the US in 2017 and later approved in the US as an interchangeable biosimilar to Humira in October 2021. A lower concentration version of CYLTEZO (50 mg/mL) has been on the market since July 2023.
FDA lifts hold on Larimar's Friedreich's Ataxia drug study By Investing.com
Investing.com· 15 hours agoS. Food and Drug Administration (FDA) has lifted the partial clinical hold on its nomlabofusp...
